Deltex Medical Group plc logo

Deltex Medical Group plc (DTXMF)

Market Closed
4 Aug, 20:00
OTC PINK OTC PINK
$
0. 10
0
0%
$
180.58M Market Cap
- P/E Ratio
- Div Yield
55,000 Volume
- Eps
$ 0.1
Previous Close
Add Transaction
Day Range
0.1 0.1
Year Range
0.1 0.1
Want to track DTXMF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

DTXMF closed Tuesday higher at $0.1, an increase of 0% from Monday's close, completing a monthly increase of 0% or $0. Over the past 12 months, DTXMF stock lost 0%.
DTXMF is not paying dividends to its shareholders.
The last earnings report, released on Apr 02, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

DTXMF Chart

People also search for

American Oncology Network Inc.
$ 10
0%
Northwest Biotherapeutics Inc.
$ 0.19
+3.3333%
Cyberdyne Inc. Sponsored ADR
$ 1.36
0%
Implanet S.A. Sponsored ADR
$ 0.08
0%
Xvivo Perfusion AB American Depositary Receipt
$ 7.13
+9.0031%

Deltex Medical Group plc (DTXMF) FAQ

What is the stock price today?

The current price is $0.10.

On which exchange is it traded?

Deltex Medical Group plc is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is DTXMF.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 180.58M.

Has Deltex Medical Group plc ever had a stock split?

No, there has never been a stock split.

Deltex Medical Group plc Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Natalie Emilia Wettler CEO
OTC PINK Exchange
GB0059337583 ISIN
GB Country
24 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Deltex Medical Group plc, headquartered in Chichester, the United Kingdom, is a global leader in the manufacture, marketing, and sale of haemodynamic monitoring systems, specifically oesophageal doppler systems, which are sold under the TrueVue brand. Founded in 2000, the company operates both in the United Kingdom and internationally, including the United States. Deltex Medical Group plc's innovative products are pivotal in guiding fluid and drug interventions, as well as in monitoring haemodynamic variables during a variety of medical procedures and conditions such as sepsis, various surgeries, cardiac, trauma, transplant procedures, and post-operative acute kidney injury monitoring.

Products and Services

  • Oesophageal Doppler Probes - These probes are advanced tools designed for haemodynamic monitoring. Used during medical procedures, they help in guiding fluid and drug interventions by providing detailed insights into the patient's cardiovascular health.
  • TrueVue System - The TrueVue monitoring system offers a comprehensive solution for haemodynamic management. It incorporates a range of functionalities, including the TrueVue Loops, which plots aortic blood flow velocity and aortic blood pressure, providing clinicians with critical information for patient care.
  • High Definition Impedance Cardiography - This non-invasive system is aimed at awake patients for cardiac function and fluid status monitoring. It offers an alternative to more invasive methods, delivering crucial data on cardiac health without necessitating procedural sedation or invasive catheterization.
  • DoppLink - A patient interface cable that enhances the processing of the signal from the monitoring probes. This technological enhancement ensures better data quality and integrity, facilitating accurate patient monitoring and assessment.
  • PressureWave - Featuring a pulse contour analysis algorithm, PressureWave is designed to provide precise and non-invasive monitoring of pulse waveforms and heart function, further enriching the data clinicians have for decision-making.
  • Deltex Medical Esophageal Doppler Simulator - This innovative simulation device allows clinicians to practice probe insertion, focusing, and waveform interpretation in a non-patient setting, thereby improving their proficiency and reducing the risk of errors during actual medical procedures.

Contact Information

Address: Terminus Road
Phone: 44 12 4377 4837